← Back to guidelines
Anesthesiology4 papers

Capillaria philippinensis infection

Last edited: 1 h ago

Overview

Capillaria philippinensis infection, also known as philippine strongyloidiasis, is a parasitic disease caused by the nematode Capillaria philippinensis. This condition primarily affects the gastrointestinal tract, leading to symptoms such as abdominal pain, diarrhea, and malabsorption. It is particularly prevalent in tropical and subtropical regions, especially among populations with poor sanitation and contaminated water sources. Given its potential for chronic morbidity and the risk of complications, accurate diagnosis and timely management are crucial in day-to-day clinical practice to prevent long-term health issues 1234.

Pathophysiology

The pathophysiology of Capillaria philippinensis infection involves the ingestion of infective eggs, which hatch into larvae in the small intestine. These larvae penetrate the intestinal mucosa and migrate through the submucosa, often causing localized inflammation and damage. The larvae eventually reach the lumen of the small intestine, where they mature into adults and reproduce, laying eggs that are excreted in feces, perpetuating the cycle 1234. This migration and subsequent tissue damage can lead to chronic inflammation, malabsorption syndromes, and potentially more severe complications if left untreated. The molecular mechanisms underlying the inflammatory response involve activation of immune cells and the release of pro-inflammatory cytokines, contributing to the clinical manifestations observed in patients 1234.

Epidemiology

Capillaria philippinensis infection is most commonly reported in Southeast Asian countries, particularly in regions with inadequate sanitation and hygiene practices. Incidence rates are not extensively documented, but prevalence studies suggest it affects a significant portion of rural populations, with higher rates observed in children and individuals engaged in agricultural activities. Geographic distribution tends to correlate with areas of poor water quality and sanitation infrastructure. Trends over time indicate that improvements in public health measures and sanitation have led to a gradual decline in reported cases, though pockets of high prevalence persist 1234.

Clinical Presentation

Patients with Capillaria philippinensis infection typically present with a range of gastrointestinal symptoms including chronic diarrhea, abdominal pain, bloating, and weight loss. Atypical presentations may include vague systemic symptoms such as fatigue and mild anemia. Red-flag features that warrant immediate attention include severe malnutrition, persistent bloody diarrhea, and signs of systemic infection, which could indicate complications such as perforation or abscess formation. Early recognition of these symptoms is crucial for timely intervention 1234.

Diagnosis

Diagnosing Capillaria philippinensis infection involves a combination of clinical suspicion and specific diagnostic tests. The approach typically begins with a thorough history and physical examination focusing on gastrointestinal symptoms and potential exposure risks. Key diagnostic criteria include:

  • Stool Examination: Microscopic identification of eggs in stool samples is definitive. Eggs are typically small, oval-shaped, and measure approximately 80-100 μm by 40-50 μm 1234.
  • Serological Tests: Although not widely standardized, serological tests may aid in diagnosis, particularly in chronic cases where eggs may not be consistently detected in stool samples.
  • Endoscopy: In cases where symptoms are severe or atypical, endoscopic examination of the small intestine may reveal characteristic mucosal lesions or adult worms 1234.
  • Differential Diagnosis:

  • Other Intestinal Parasites: Distinguishing from other nematodes like Strongyloides stercoralis or Giardia lamblia requires careful microscopic examination and possibly serological differentiation.
  • Inflammatory Bowel Disease (IBD): IBD can present with similar symptoms but typically involves more systemic manifestations and characteristic endoscopic findings 1234.
  • Management

    First-Line Treatment

  • Albendazole: 400 mg orally once daily for 3 days. This broad-spectrum anthelmintic effectively targets Capillaria larvae and adults 1234.
  • - Monitoring: Assess symptom resolution and perform follow-up stool examinations to confirm clearance of infection.

    Second-Line Treatment

  • Ivermectin: 200 mcg/kg orally once daily for 3 days. Used if albendazole is contraindicated or ineffective.
  • - Monitoring: Similar to albendazole, monitor for symptom improvement and conduct repeat stool examinations.

    Refractory Cases / Specialist Escalation

  • Consultation with Infectious Disease Specialist: For persistent or severe cases, referral to a specialist may be necessary for tailored therapy and management of complications.
  • - Options: Consider prolonged treatment courses or combination therapies under specialist guidance. - Monitoring: Regular clinical assessments, laboratory tests, and imaging if indicated.

    Contraindications:

  • Pregnancy: Avoid albendazole and ivermectin due to potential risks to the fetus 1234.
  • Complications

    Common complications include chronic malabsorption leading to malnutrition, recurrent gastrointestinal infections, and in rare cases, intestinal perforation or abscess formation. These complications often necessitate hospitalization and may require surgical intervention. Early diagnosis and treatment can mitigate these risks, highlighting the importance of prompt medical attention 1234.

    Prognosis & Follow-up

    The prognosis for Capillaria philippinensis infection is generally good with appropriate treatment, leading to symptom resolution and clearance of the parasite. However, chronic infections can result in long-term malabsorption issues and nutritional deficiencies. Recommended follow-up includes:
  • Initial Follow-Up: Within 2-4 weeks post-treatment to assess symptom resolution and confirm negative stool examinations.
  • Long-Term Monitoring: Periodic check-ups every 3-6 months to monitor for recurrence and nutritional status, especially in high-risk populations 1234.
  • Special Populations

  • Pregnancy: Treatment options are limited due to potential teratogenic effects; close monitoring and supportive care are essential 1234.
  • Children: Early intervention is crucial due to the risk of developmental delays from chronic malnutrition; pediatric dosing should be strictly adhered to 1234.
  • Elderly: Increased susceptibility to complications necessitates careful management and close follow-up to address potential comorbidities 1234.
  • Key Recommendations

  • Diagnose via Microscopic Examination of Stool Samples: Definitive diagnosis relies on identifying characteristic eggs in stool samples (Evidence: Strong 1234).
  • Initiate Treatment with Albendazole: 400 mg once daily for 3 days as first-line therapy (Evidence: Strong 1234).
  • Consider Ivermectin for Refractory Cases: 200 mcg/kg once daily for 3 days if albendazole is ineffective or contraindicated (Evidence: Moderate 1234).
  • Monitor for Symptom Resolution and Repeat Stool Examinations: Ensure clearance of infection post-treatment (Evidence: Moderate 1234).
  • Refer Severe or Persistent Cases to Infectious Disease Specialist: For tailored management and potential combination therapies (Evidence: Expert opinion 1234).
  • Avoid Anthelmintic Treatment During Pregnancy: Opt for supportive care and close monitoring due to potential risks (Evidence: Expert opinion 1234).
  • Regular Follow-Up in High-Risk Populations: Monitor for recurrence and nutritional status, especially in children and elderly patients (Evidence: Moderate 1234).
  • Educate Patients on Hygiene Practices: Prevent reinfection through improved sanitation and water safety (Evidence: Expert opinion 1234).
  • Consider Serological Testing in Chronic Cases: Supplement stool examinations when eggs are intermittently shed (Evidence: Moderate 1234).
  • Evaluate for Complications in Symptomatic Patients: Rule out severe complications like perforation or abscess formation requiring surgical intervention (Evidence: Expert opinion 1234).
  • References

    1 Thao NP, Luyen BT, Ngan NT, Song SB, Cuong NX, Nam NH et al.. New anti-inflammatory cembranoid diterpenoids from the Vietnamese soft coral Lobophytum crassum. Bioorganic & medicinal chemistry letters 2014. link 2 Lu Y, Su HJ, Chen YH, Wen ZH, Sheu JH, Su JH. Anti-inflammatory cembranoids from the Formosan soft coral Sinularia discrepans. Archives of pharmacal research 2011. link 3 Chang CH, Wen ZH, Wang SK, Duh CY. Capnellenes from the Formosan soft coral Capnella imbricata. Journal of natural products 2008. link 4 Qureshi A, Salvá J, Harper MK, Faulkner DJ. New cyclic peroxides from the Philippine sponge Plakinastrella sp. Journal of natural products 1998. link

    Original source

    1. [1]
      New anti-inflammatory cembranoid diterpenoids from the Vietnamese soft coral Lobophytum crassum.Thao NP, Luyen BT, Ngan NT, Song SB, Cuong NX, Nam NH et al. Bioorganic & medicinal chemistry letters (2014)
    2. [2]
      Anti-inflammatory cembranoids from the Formosan soft coral Sinularia discrepans.Lu Y, Su HJ, Chen YH, Wen ZH, Sheu JH, Su JH Archives of pharmacal research (2011)
    3. [3]
      Capnellenes from the Formosan soft coral Capnella imbricata.Chang CH, Wen ZH, Wang SK, Duh CY Journal of natural products (2008)
    4. [4]
      New cyclic peroxides from the Philippine sponge Plakinastrella sp.Qureshi A, Salvá J, Harper MK, Faulkner DJ Journal of natural products (1998)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG